Familial mutations modulate α-synuclein interactions with key neuronal membrane lipids

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Parkinson's disease (PD) involves alpha-synuclein (α-Syn) aggregation in the brain.
• Familial PD mutations (A30P, E46K, A53T, H50Q) are linked to early and late-onset disease.
• Lipids like phospholipids and cholesterol affect wild-type α-Syn aggregation, but their impact on mutant forms is less understood.

Purpose of the Study:

• To investigate how neuronal membrane lipids influence the aggregation rates of familial PD-associated α-Syn mutants.
• To determine if specific mutations alter α-Syn interaction with lipid bilayers.
• To assess the impact of these lipid interactions on α-Syn fibril morphology, secondary structure, and cytotoxicity.

Main Methods:

• Aggregation assays of wild-type (WT) and mutant α-Syn (A30P, E46K, A53T, H50Q) in the presence of large unilamellar vesicles (LUVs).
• LUVs composed of phosphatidylcholine (PC), sphingomyelin (SM), and cholesterol (Cho).
• Biophysical techniques to analyze fibril morphology and secondary structure.

Main Results:

• Familial mutations uniquely altered α-Syn interactions with lipid bilayers, affecting aggregation rates.
• The A30P mutation completely inhibited α-Syn interaction with LUVs.
• Mutations E46K, A53T, and H50Q modified the cytotoxicity of α-Syn fibrils formed with lipids.

Conclusions:

• Familial PD mutations distinctly modify α-Syn's interaction with neuronal lipids.
• Altered protein-lipid interactions can influence the aggregation kinetics and cytotoxicity of α-Syn.
• Changes in neuronal membrane lipid composition may play a significant role in the pathogenesis of familial PD.